Literature DB >> 11318802

The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation?

Y K Mak1, P H Yu, C H Chan, Y C Chu.   

Abstract

We performed a retrospective analysis of bone marrow examination (BME) in the management of Chinese adult patients less than 60 years of age with isolated thrombocytopenia at presentation. Eighty-three patients with a median age of 39 years presenting with isolated thrombocytopenia (median platelet count: 38 x 10(9)/l) had routinely undergone BME as part of the laboratory investigations during the period from January 1996 to December 1999. All 83 patients had bone marrow findings of active marrow suggesting causes due to peripheral destruction. All of these patients responded to steroid or intravenous immunoglobulin (IVIg) therapy at presentation if their platelet counts were significantly low or if they had mucosal bleeding. Eighty-one of the 83 patients, after a median of 20 months follow-up, were finally diagnosed as having idiopathic thrombocytopenic purpura (ITP). The remaining two patients were finally confirmed as cases of systemic lupus erythematosus (SLE). Our results suggest that BME is not helpful in the diagnosis of isolated thrombocytopenia or suspected ITP in adult patients at presentation, provided that a thorough clinical history and physical examination are undertaken and that the blood count and peripheral blood smear show no abnormalities apart from the thrombocytopenia.

Entities:  

Mesh:

Year:  2000        PMID: 11318802     DOI: 10.1046/j.1365-2257.2000.00340.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  4 in total

1.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

2.  Re-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia Contributors.

Authors:  Abhishek Purohit; Mukul Aggarwal; Pawan Kumar Singh; Manoranjan Mahapatra; Tulika Seth; Seema Tyagi; Renu Saxena; Hara P Pati; Pravas Mishra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-03-28       Impact factor: 0.900

3.  Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.

Authors:  Margareth Castro Ozelo; Marina Pereira Colella; Erich Vinícius de Paula; Ana Clara Kneese Virgilio do Nascimento; Paula Ribeiro Villaça; Wanderley Marques Bernardo
Journal:  Hematol Transfus Cell Ther       Date:  2018-02-17

4.  Primary immune thrombocytopenia: a 'diagnosis of exclusion'?

Authors:  Nathan Visweshwar; Irmel Ayala; Michael Jaglal; Robert Killeen; Lubomir Sokol; Damian A Laber; Arumugam Manoharan
Journal:  Blood Coagul Fibrinolysis       Date:  2022-07-29       Impact factor: 1.061

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.